Cargando…
The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease
Mitochondrial dysfunction within the eye contributes to primarily mitochondrial diseases affecting the visual system such as Leber hereditary optic neuropathy (LHON) as well as more common ocular diseases, including glaucoma, diabetic retinopathy, retinopathy of prematurity, and age-related macular...
Autores principales: | Ji, Marco H., Kreymerman, Alexander, Belle, Kinsley, Ghiam, Benjamin K., Muscat, Stephanie R., Mahajan, Vinit B., Enns, Gregory M., Mercola, Mark, Wood, Edward H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267180/ https://www.ncbi.nlm.nih.gov/pubmed/34232272 http://dx.doi.org/10.1167/tvst.10.8.4 |
Ejemplares similares
-
Erratum in: The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease
Publicado: (2023) -
CRB1 related retinal degeneration with novel mutation
por: Ghiam, Benjamin K., et al.
Publicado: (2020) -
Calpain-5 gene expression in the mouse eye and brain
por: Schaefer, Kellie, et al.
Publicado: (2017) -
Consolidating in the present, with an eye to the future
por: Souza, Rogerio
Publicado: (2016) -
Investigation of Cas9 antibodies in the human eye
por: Toral, Marcus A., et al.
Publicado: (2022)